Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Inivata (Group)

Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients. The Company’s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge and reinforced by multiple high calibre publications. Its lead product, InVisionFirst™-Lung, is commercially available and provides molecular insights that enable clinicians to make more informed treatment decisions for NSCLC patients. Inivata is partnering with pharmaceutical and biotechnology companies on InVisionFirst™-Lung and its wider platform, which is applicable to a range of cancer types. The Company has a CLIA laboratory in Research Triangle Park, NC and laboratories in Cambridge, UK. *


Period Start 2014-09-01 splitoff
Period End 2021-05-05 acquired
Product Industry cancer test, molecular diagnostics
Persons Person Stocum, Michael (Inivata 201603 CEO)
  Person 2 Rosenfeld, Nitzan (Inivata 201603 CSO)
Region Region Cambridge, Cambridgeshire
  Country United Kingdom (GB)
  Street The Portway Building
Granta Park
  City CB21 6GS Cambridge, Cambridgeshire
  Tel +44-1223-790880
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Inivata Ltd.. (3/28/19). "Press Release: Inivata Completes $52.6m (£39.8m) Series B Funding Round". Research Triangle Park, NC & Cambridge.
Record changed: 2021-05-08


Picture [iito] No Tracking 650x80px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Fighting Customers 650x80px

» top